Literature DB >> 22372521

Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum).

Deborah Delair1, Robert A Soslow.   

Abstract

Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum) Ovarian serous carcinoma (OSC) is the most common of the ovarian epithelial malignancies, and accounts for most of the mortality. Traditionally, ovarian cancer has been considered to be one disease; however, it is now apparent that it actually consists of many different entities. OSC can be further segregated into two processes: high-grade serous carcinoma (HGSC) and low-grade serous carcinoma. This classification is supported by molecular changes, morphological appearance, clinical behaviour, and distinct precursor lesions. This review will describe in detail these features of OSC, differential diagnosis, prognosis, and recent challenges to the existing hypotheses regarding the origin of these tumours. Special attention will be paid to HGSC and its relationship with BRCA abnormalities, especially those seen in hereditary breast and ovarian cancer syndrome. Finally, treatment options based on specific molecular targets will be discussed.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22372521     DOI: 10.1111/j.1365-2559.2011.04167.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

Review 1.  Prognostic biomarkers in endometrial and ovarian carcinoma.

Authors:  Xavier Matias-Guiu; Ben Davidson
Journal:  Virchows Arch       Date:  2014-02-07       Impact factor: 4.064

2.  Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis.

Authors:  Yiying Wang; Li Li; Yue Wang; Sarah Ngocvi Tang; Wenxin Zheng
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

3.  Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis.

Authors:  Yiying Wang; Li Li; Yue Wang; Sarah Ngocvi Tang; Wenxin Zheng
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

4.  Three-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma.

Authors:  Hilal Gurler; Yi Yu; Jacqueline Choi; Andre A Kajdacsy-Balla; Maria V Barbolina
Journal:  Int J Mol Sci       Date:  2015-02-04       Impact factor: 5.923

5.  Abdominopelvic washings: A comprehensive review.

Authors:  Erika F Rodriguez; Sara E Monaco; Walid Khalbuss; R Marshall Austin; Liron Pantanowitz
Journal:  Cytojournal       Date:  2013-04-24       Impact factor: 2.091

6.  IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis.

Authors:  Yiying Wang; Lingmin Li; Yue Wang; Zeng Yuan; Wenjing Zhang; Kenneth D Hatch; Wenxin Zheng
Journal:  J Exp Clin Cancer Res       Date:  2014-07-20

7.  IMP3 signatures of fallopian tube: a risk for pelvic serous cancers.

Authors:  Yiying Wang; Yue Wang; Dake Li; Lingmin Li; Wenjing Zhang; Guang Yao; Zhong Jiang; Wenxin Zheng
Journal:  J Hematol Oncol       Date:  2014-07-12       Impact factor: 17.388

Review 8.  Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG).

Authors:  Miseon Kim; Young-Han Kim; Yong Beom Kim; Jayeon Kim; Jae-Weon Kim; Mi Hye Park; Joo Hyun Park; Jeong Ho Rhee; Myong Cheol Lim; Joon-Seok Hong
Journal:  Obstet Gynecol Sci       Date:  2018-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.